Merck & Co Intangible Assets
Intangible Assets of Merck & Co (MRK) as of Sep 10, 2026.
Get this data via API
Financial Data API
Intangible Assets
0.00USD
Last updated:
The Merck & Co Intangible Assets history
3 Years
10 Years
25 Years
Max
| YEAR | Intangible Assets | YoY |
|---|---|---|
| 21.58 BUSD | +31.82% | |
| 16.37 BUSD | -9.11% | |
| 18.01 BUSD | -11.14% | |
| 20.27 BUSD | -11.62% | |
| 22.93 BUSD | +57.03% | |
| 14.60 BUSD | +2.87% | |
| 14.20 BUSD | +24.19% | |
| 11.43 BUSD | -19.40% | |
| 14.18 BUSD | -18.04% | |
| 17.31 BUSD | -23.44% | |
| 22.60 BUSD | +10.87% | |
| 20.39 BUSD | -43.53% | |
| 36.10 BUSD | -12.41% | |
| 41.22 BUSD | -11.28% | |
| 46.46 BUSD | -10.37% | |
| 51.83 BUSD | -13.31% | |
| 59.80 BUSD | +2,944.40% | |
| 1.96 BUSD | -9.40% | |
| 2.17 BUSD | -8.74% | |
| 2.38 BUSD | +48.06% | |
| 1.60 BUSD | +80.63% | |
| 888.20 MUSD | -54.44% | |
| 1.95 BUSD | -73.08% | |
| 7.24 BUSD | -2.99% | |
| 7.46 BUSD | +96.42% | |
| 3.80 BUSD | — | |
| 0.00USD | — | |
| 0.00USD | — | |
| 0.00USD | — | |
| 0.00USD | — | |
| 0.00USD | — | |
| 0.00USD | — | |
| 0.00USD | — | |
| 0.00USD | — | |
| 0.00USD | — | |
| 0.00USD | — | |
| 0.00USD | — | |
| 0.00USD | — | |
| 0.00USD | — | |
| 0.00USD | — | |
| 0.00USD | — | |
| 0.00USD | — | |
| 0.00USD | — |
Merck & Co Stock analysis
Frequently Asked Questions about Merck & Co stock
On Eulerpool you can find the complete historical development of Intangible Assets Merck & Co since 2006 – with annual values, charts, and detailed analysis.
Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.
Intangible Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's Merck & Co historically and in real time.
Balance Sheet — Merck & Co
All Key Metrics — Merck & Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth